CRLF2 and acute lymphoblastic leukemia: Individuals with DS are at a 20-fold risk for developing B-ALL compared to the general population [172] and 60% of B-ALL cases in DS harbor the rearrangement of cytokine receptor-like factor 2 (CRLF2) further classifying it as DS-ALL [173].